Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet activating factor mediates cardiopulmonary dysfunction during graded bacteremic shock

D S Woolley1, R N Puglisi, J V Quinn

  • 1Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, USA.

The Journal of Trauma
|August 1, 1996
PubMed
Summary

Platelet activating factor (PAF) is essential for cardiovascular dysfunction during bacteremia, driving vasodilation and hypotension. Blocking PAF with WEB 2086 improved hemodynamics and reduced inflammatory mediators.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phonon-Assisted Resonant Tunneling of Electrons in Graphene-Boron Nitride Transistors.

Physical review letters·2016
Same author

Effect of Structural Relaxation on the Electronic Structure of Graphene on Hexagonal Boron Nitride.

Physical review letters·2015
Same author

Molecular structural requirements for binding and activation of L-alanine taste receptors.

Amino acids·2013
Same author

Structure, stability and defects of single layer hexagonal BN in comparison to graphene.

Journal of physics. Condensed matter : an Institute of Physics journal·2012
Same author

Quantitative analysis of organ tissue damage after septic shock.

The American surgeon·2007
Same author

Patterns of complementary and alternative medicine use in ED patients and its association with health care utilization.

The American journal of emergency medicine·2004

Area of Science:

  • Cardiovascular Physiology
  • Sepsis Pathophysiology
  • Inflammatory Mediators

Background:

  • Sepsis-induced cardiovascular dysfunction is a critical complication.
  • The role of platelet activating factor (PAF) in sepsis is not fully understood.
  • Interactions between PAF, eicosanoids, and TNF-alpha require elucidation.

Purpose of the Study:

  • To investigate if PAF is a necessary mediator of cardiovascular dysfunction during graded bacteremia.
  • To identify potential interactions between PAF, eicosanoids (TXB2, PGI2, LTB4, LTC4D4E4), and TNF-alpha.

Main Methods:

  • Adult swine were subjected to graded bacteremia (Aeromonas hydrophila).
  • One group received a PAF receptor antagonist (WEB 2086) during bacteremia.
  • Cardiopulmonary parameters and plasma levels of eicosanoids and TNF-alpha were measured.

Related Experiment Videos

Main Results:

  • WEB 2086 administration prevented systemic vasodilation, hypotension, and pulmonary hypertension.
  • PAF antagonism normalized arterial pH and reduced oxygen consumption.
  • Plasma levels of TXB2, PGI2, LTB4, and TNF-alpha were significantly lower in the WEB 2086 group.

Conclusions:

  • PAF is a critical mediator of cardiovascular dysfunction in bacteremia.
  • PAF antagonism improves hemodynamic stability and metabolic acidosis.
  • PAF-induced release of eicosanoids and TNF-alpha likely contributes to sepsis pathophysiology.